A detailed history of Bank Of America Corp transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 211 shares of VIRI stock, worth $936. This represents 0.0% of its overall portfolio holdings.

Number of Shares
211
Previous 139 51.8%
Holding current value
$936
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.17 - $0.29 $12 - $20
72 Added 51.8%
211 $0
Q2 2024

Aug 14, 2024

BUY
$0.18 - $0.58 $25 - $80
139 New
139 $0
Q1 2022

May 16, 2022

SELL
$4.48 - $6.92 $35 - $55
-8 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$4.07 - $6.12 $32 - $48
8 New
8 $0

Others Institutions Holding VIRI

About Virios Therapeutics, Inc.


  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $81.4M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.